To enable the development of innovative solutions to address future healthcare demands, MOHH supports the National Medical Research Council (NMRC) and Ministry of Health in advancing Singapore’s biomedical research agenda. 

Driving biomedical innovation

Research, Innovation and Enterprise (RIE) is a strategic national five-year plan that serves as a cornerstone of Singapore’s development into a knowledge-based, innovation-driven economy and society. Renewed every five years, it plays a crucial role as a key enabler in creating new avenues of growth, raising Singapore’s economic competitiveness, and driving scientific breakthroughs that meet our societal needs and improve the lives of Singaporeans.

MOHH supports NMRC in furthering biomedical research, including awarding and administering grants under the RIE Human Health and Potential domain, which looks to better transform and protect health, advance human potential, and create economic value for Singapore. 

Supporting research enablers and infrastructure initiatives

We also support the development, maintenance, and enhancement of research enablers and infrastructure initiatives which align with Singapore’s continuous push to strengthen translational and clinical research capabilities, with the goal of improving both health outcome and economic growth.

To enhance support for research work and aid in planning future funding strategies and resource allocation, MOHH supports initiatives like the NMRC Clinician Scientists/Innovators engagement sessions. These sessions aimed to gain a deeper understanding of the needs and challenges our clinician scientists and innovators face in their research work.